project id: TCGA-LUAD; case submitter id: TCGA-64-5779; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 61; days to birth: -22305; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 22305; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 864.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8550/3; primary diagnosis: Acinar cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; years smoked: 40.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.0; longest dimension: 1.3; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-64-5779-01A-01; percent lymphocyte infiltration: 12.0; percent monocyte infiltration: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 75.0;